Collegium Pharmaceutical (COLL)
(Delayed Data from NSDQ)
$38.93 USD
-0.41 (-1.04%)
Updated Oct 17, 2024 04:00 PM ET
After-Market: $38.90 -0.03 (-0.08%) 6:40 PM ET
2-Buy of 5 2
A Value A Growth F Momentum A VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 30% (74 out of 250)Zacks Sector Rank
Top 6% (1 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.80 | 1.55 | 9.99 |
Current Quarter Estimate | 1.63 | 0.07 | 63.00 |
Year Ago Quarter Estimate | 1.34 | 0.12 | 52.25 |
Next Quarter Estimate | 1.67 | -2.02 | 66.00 |
Next Year Estimate | 6.87 | 11.91 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 15.54 | 17.50 | 15.67 |
Next Year | 8.70 | 16.70 | 11.34 |
Last 5 Years | NA | 5.00 | 8.10 |
Next 5 Years | NA | 20.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 6.57 | -2.52 |
Price/Book (MRQ) | 5.94 | 1.54 |
Price/Cash Flow (MRFY) | 3.65 | 8.35 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 17.32% | -203.98% |
Return on Equity (TTM) | 107.62% | -81.98% |
Debt to Equity (MRQ) | NA | 0.64 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.